Recent advances and challenges of immune checkpoint inhibitors in immunotherapy of non-small cell lung cancer
Zhuzhu Wu, Shuai Man, Rui Sun, Zengqiang Li, Yingliang Wu, Daiying Zuo
Topics & Concepts
AtezolizumabDurvalumabTremelimumabNivolumabPembrolizumabIpilimumabMedicineImmunotherapyAvelumabOncologyLung cancerCancerCTLA-4Internal medicineImmunologyClinical trialT cellImmune systemCancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsPancreatic and Hepatic Oncology Research